{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:38:13Z","timestamp":1767994693916,"version":"3.49.0"},"publisher-location":"Cham","reference-count":91,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030648718","type":"print"},{"value":"9783030648725","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-64872-5_2","type":"book-chapter","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T12:40:06Z","timestamp":1618576806000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of Curcumin in Regulating Long Noncoding RNA Expression in Cancer"],"prefix":"10.1007","author":[{"given":"Abolfazl","family":"Amini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parand","family":"Khadivar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ahmadnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"issue":"9","key":"2_CR1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4161\/cbt.6.9.4543","volume":"6","author":"JY Zhang","year":"2007","unstructured":"Zhang JY, Wu HY, Xia XK, Liang YJ, Yan YY, She ZG et al (2007) Anthracenedione derivative 1403P-3 induces apoptosis in KB and KBv200 cells via reactive oxygen species-independent mitochondrial pathway and death receptor pathway. Cancer Biol Ther 6(9):1409\u20131417","journal-title":"Cancer Biol Ther"},{"issue":"32","key":"2_CR2","doi-asserted-by":"crossref","first-page":"32790","DOI":"10.18632\/oncotarget.5411","volume":"6","author":"QW Jiang","year":"2015","unstructured":"Jiang QW, Cheng KJ, Mei XL, Qiu JG, Zhang WJ, Xue YQ et al (2015) Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. Oncotarget 6(32):32790\u201332804","journal-title":"Oncotarget"},{"issue":"15","key":"2_CR3","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4161\/cc.8.15.9170","volume":"8","author":"JY Zhang","year":"2009","unstructured":"Zhang JY, Tao LY, Liang YJ, Yan YY, Dai CL, Xia XK et al (2009) Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3\u03b2\/\u03b2-catenin\/c-Myc pathway. Cell Cycle 8(15):2444\u20132450","journal-title":"Cell Cycle"},{"issue":"19","key":"2_CR4","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/onc.2014.171","volume":"34","author":"Z Shi","year":"2015","unstructured":"Shi Z, Li Z, Li Z, Cheng K, Du Y, Fu H et al (2015) Cables1 controls p21\/Cip1 protein stability by antagonizing proteasome subunit alpha type 3. Oncogene 34(19):2538\u20132545","journal-title":"Oncogene"},{"issue":"9","key":"2_CR5","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/molecules22091412","volume":"22","author":"JY Zhang","year":"2017","unstructured":"Zhang JY, Huang WJ, Sun HM, Liu Y, Zhao XQ, Tang SL et al (2017) Structure identification and in vitro anticancer activity of lathyrol-3-phenylacetate-5, 15-diacetate. Molecules 22(9):1412. https:\/\/doi.org\/10.3390\/molecules22091412","journal-title":"Molecules"},{"issue":"22","key":"2_CR6","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1158\/0008-5472.CAN-07-2686","volume":"67","author":"Z Shi","year":"2007","unstructured":"Shi Z, Peng X-X, Kim I-W, Shukla S, Si QS, Robey RW et al (2007) Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2\u2013mediated drug resistance. Cancer Res 67(22):11012\u201311020","journal-title":"Cancer Res"},{"issue":"10","key":"2_CR7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2174\/1871520617666170419120044","volume":"17","author":"J Zhang","year":"2017","unstructured":"Zhang J, Lai Z, Huang W, Ling H, Lin M, Tang S et al (2017) Apicidin inhibited proliferation and invasion and induced apoptosis via mitochondrial pathway in non-small cell lung cancer GLC-82 cells. Anti-Cancer Agent Me 17(10):1374\u20131382","journal-title":"Anti-Cancer Agent Me"},{"issue":"4","key":"2_CR8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.23021","volume":"112","author":"JY Zhang","year":"2011","unstructured":"Zhang JY, Mi YJ, Chen SP, Wang F, Liang YJ, Zheng LS et al (2011) Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion. J Cell Biochem 112(4):1076\u20131083","journal-title":"J Cell Biochem"},{"issue":"1","key":"2_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570163812666150602144310","volume":"12","author":"TA Baudino","year":"2015","unstructured":"Baudino TA (2015) Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol 12(1):3\u201320","journal-title":"Curr Drug Discov Technol"},{"issue":"7","key":"2_CR10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/0929866526666190311163820","volume":"26","author":"DO Acheampong","year":"2019","unstructured":"Acheampong DO (2019) Bispecific antibody (bsAb) construct formats and their application in cancer therapy. Protein Pept Lett 26(7):479\u2013493","journal-title":"Protein Pept Lett"},{"issue":"12","key":"2_CR11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.tips.2018.10.004","volume":"39","author":"AS Limpert","year":"2018","unstructured":"Limpert AS, Lambert LJ, Bakas NA, Bata N, Brun SN, Shaw RJ et al (2018) Autophagy in cancer: regulation by small molecules. Trends Pharmacol Sci 39(12):1021\u20131032","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"2_CR12","doi-asserted-by":"publisher","first-page":"101042831769222","DOI":"10.1177\/1010428317692226","volume":"9","author":"H Allahyari","year":"2017","unstructured":"Allahyari H, Heidari S, Ghamgosha M, Saffarian P, Amani J (2017) Immunotoxin: a new tool for cancer therapy. Tumour Biol 9(2):1010428317692226. https:\/\/doi.org\/10.1177\/1010428317692226","journal-title":"Tumour Biol"},{"issue":"2","key":"2_CR13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1389450118666170508095250","volume":"19","author":"A Babazadeh","year":"2018","unstructured":"Babazadeh A, Zeinali M, Hamishehkar H (2018) Nano-phytosome: a developing platform for herbal anti-cancer agents in cancer therapy. Curr Drug Targets 19(2):170\u2013180","journal-title":"Curr Drug Targets"},{"issue":"4","key":"2_CR14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/1061186X.2018.1514040","volume":"27","author":"N Tyagi","year":"2019","unstructured":"Tyagi N, Song YH, De R (2019) Recent progress on biocompatible nanocarrier-based genistein delivery systems in cancer therapy. J Drug Target 27(4):394\u2013407","journal-title":"J Drug Target"},{"issue":"Suppl2","key":"2_CR15","first-page":"33","volume":"17","author":"M Fazel","year":"2018","unstructured":"Fazel M, Daeihamed M, Osouli M, Almasi A, Haeri A, Dadashzadeh S (2018) Preparation, in-vitro characterization and pharmacokinetic evaluation of Brij decorated doxorubicin liposomes as a potential nanocarrier for cancer therapy. Iran J Pharm Res 17(Suppl2):33\u201343","journal-title":"Iran J Pharm Res"},{"issue":"8","key":"2_CR16","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdy230","volume":"29","author":"D Papamichael","year":"2018","unstructured":"Papamichael D, Glynne-Jones R (2018) Identifying patients who may benefit from oxaliplatin-containing perioperative chemo(radio)therapy for rectal cancer. Ann Oncol 29(8):1616\u20131618","journal-title":"Ann Oncol"},{"issue":"4","key":"2_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrclinonc.2017.207","volume":"15","author":"I Vaz-Luis","year":"2018","unstructured":"Vaz-Luis I, Partridge AH (2018) Exogenous reproductive hormone use in breast cancer survivors and previvors. Nat Rev Clin Oncol 15(4):249\u2013261","journal-title":"Nat Rev Clin Oncol"},{"issue":"1328","key":"2_CR18","first-page":"211","volume":"222","author":"BA Stoll","year":"1979","unstructured":"Stoll BA (1979) Endocrine therapy in cancer. Practitioner 222(1328):211\u2013217","journal-title":"Practitioner"},{"issue":"2","key":"2_CR19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3748\/wjg.v22.i2.790","volume":"22","author":"XM Luo","year":"2016","unstructured":"Luo XM, Niu LZ, Chen JB, Xu KC (2016) Advances in cryoablation for pancreatic cancer. World J Gastroenterol 22(2):790\u2013800","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2_CR20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/02656736.2017.1387940","volume":"34","author":"T Si","year":"2018","unstructured":"Si T, Guo Z, Yang X, Zhang W, Xing W (2018) The oncologic results of cryoablation in prostate cancer patients with bone metastases. Int J Hyperth 34(7):1044\u20131048","journal-title":"Int J Hyperth"},{"issue":"4","key":"2_CR21","first-page":"819","volume":"6","author":"JY Zhang","year":"2016","unstructured":"Zhang JY, Lin MT, Tung HY, Tang SL, Yi T, Zhang Y-Z et al (2016) Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway. Am J Cancer Res 6(4):819\u2013826","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chembiol.2017.10.009","volume":"25","author":"NM McLoughlin","year":"2018","unstructured":"McLoughlin NM, Mueller C, Grossmann TN (2018) The therapeutic potential of PTEN modulation: targeting strategies from gene to protein. Cell Chem Biol 25(1):19\u201329","journal-title":"Cell Chem Biol"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gene.2017.08.008","volume":"631","author":"T Liu","year":"2017","unstructured":"Liu T, Chi H, Chen J, Chen C, Huang Y, Xi H et al (2017) Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Gene 631:29\u201338","journal-title":"Gene"},{"issue":"4","key":"2_CR24","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/md8041469","volume":"8","author":"JY Zhang","year":"2010","unstructured":"Zhang JY, Tao LY, Liang YJ, Chen LM, Mi YJ, Zheng LS et al (2010) Anthracenedione derivatives as anticancer agents isolated from secondary metabolites of the mangrove endophytic fungi. Mar Drugs 8(4):1469\u20131481","journal-title":"Mar Drugs"},{"issue":"2","key":"2_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/1871520614666140825112255","volume":"15","author":"YW Tao","year":"2015","unstructured":"Tao YW, Lin YC, She ZG, Lin MT, Chen PX, Zhang JY (2015) Anticancer activity and mechanism investigation of beauvericin isolated from secondary metabolites of the mangrove endophytic fungi. Anti-Cancer Agent Me 15(2):258\u2013266","journal-title":"Anti-Cancer Agent Me"},{"issue":"2","key":"2_CR26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","volume":"23","author":"D Yang","year":"2013","unstructured":"Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV et al (2013) Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23(2):186\u2013199","journal-title":"Cancer Cell"},{"issue":"6","key":"2_CR27","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.3390\/molecules200611524","volume":"20","author":"JY Zhang","year":"2015","unstructured":"Zhang JY, Lin MT, Zhou MJ, Yi T, Tang YN, Tang SL et al (2015) Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 cells in vitro. Molecules 20(6):11524\u201311534","journal-title":"Molecules"},{"key":"2_CR28","doi-asserted-by":"crossref","unstructured":"Ghandadi M, Sahebkar A (2017)\u00a0Curcumin: An effective inhibitor of interleukin-6. Curr Pharm Des 23(6):921\u2013931","DOI":"10.2174\/1381612822666161006151605"},{"issue":"1","key":"2_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A (2019) Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr 59(1):89\u2013101","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2_CR30","doi-asserted-by":"crossref","unstructured":"Panahi Y, Ahmadi Y, Teymouri M,\u00a0Johnston\u00a0TP, Sahebkar A (2018) Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. J Cell Physiol 233(1):141\u2013152","DOI":"10.1002\/jcp.25756"},{"issue":"4","key":"2_CR31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40291-016-0202-7","volume":"20","author":"AA Momtazi","year":"2016","unstructured":"Momtazi AA, Derosa G, Maffioli P, Banach M, Sahebkar A (2016) Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Mol Diagn Ther 20(4):335\u2013345","journal-title":"Mol Diagn Ther"},{"issue":"3\u20134","key":"2_CR32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phymed.2009.05.020","volume":"17","author":"M Iranshahi","year":"2010","unstructured":"Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H (2010) Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 17(3\u20134):269\u2013273","journal-title":"Phytomedicine"},{"key":"2_CR33","doi-asserted-by":"crossref","unstructured":"Teymouri M, Pirro M, Johnston TP, Sahebkar A (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: a review of chemistry, cellular, molecular, and preclinical\u00a0features. Biofactors 43(3):331\u2013346","DOI":"10.1002\/biof.1344"},{"key":"2_CR34","doi-asserted-by":"crossref","unstructured":"Soleimani V, Sahebkar A,\u00a0Hosseinzadeh H (2018) Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytother Res 32(6):985\u2013995","DOI":"10.1002\/ptr.6054"},{"key":"2_CR35","doi-asserted-by":"publisher","unstructured":"Hassanzadeh S, Read MI, Bland AR, Majeed M, Jamialahmadi T, Sahebkar, A (2020) Curcumin: an inflammasome silencer. Pharmacol Res 159:104921. https:\/\/doi.org\/10.1016\/j.phrs.2020.104921","DOI":"10.1016\/j.phrs.2020.104921"},{"issue":"2","key":"2_CR36","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1002\/lary.25649","volume":"126","author":"YS Lim","year":"2016","unstructured":"Lim YS, Kwon SK, Park JH, Cho CG, Park SW, Kim WK (2016) Enhanced mucosal healing with curcumin in animal oral ulcer model. Laryngoscope 126(2):E68\u2013E73","journal-title":"Laryngoscope"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2147\/DDDT.S117432","volume":"10","author":"KY Chin","year":"2016","unstructured":"Chin KY (2016) The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis. Drug Des Devel Ther 10:3029\u20133042","journal-title":"Drug Des Devel Ther"},{"key":"2_CR38","doi-asserted-by":"publisher","unstructured":"Sadeghian M, Rahmani S, Jamialahmadi T, Johnston TP, Sahebkar A (2021) The effect of oral curcumin supplementation on health-related quality of life: A systematic review and meta-analysis of randomized controlled trials. J Affect Disord 278:627\u2013636. https:\/\/doi.org\/10.1016\/j.jad.2020.09.091","DOI":"10.1016\/j.jad.2020.09.091"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.phrs.2018.09.021","volume":"137","author":"XQ Ding","year":"2018","unstructured":"Ding XQ, Wu WY, Jiao RQ, Gu TT, Xu Q, Pan Y et al (2018) Curcumin and allopurinol ameliorate fructose-induced hepatic inflammation in rats via miR-200a-mediated TXNIP\/NLRP3 inflammasome inhibition. Pharmacol Res 137:64\u201375","journal-title":"Pharmacol Res"},{"key":"2_CR40","doi-asserted-by":"publisher","unstructured":"Saberi-Karimian\u00a0M, Keshvari M, Ghayour-Mobarhan M, Salehizadeh L, Rahmani S, Behnam B, et al (2020) Effects of curcuminoids on inflammatory status in patients with non-alcoholic\u00a0fatty liver disease: A randomized controlled trial (2020) Complement Ther Med 49:102322. https:\/\/doi.org\/10.1016\/j.phrs.2020.104921","DOI":"10.1016\/j.phrs.2020.104921"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jff.2015.01.005","volume":"18","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban MC, Ursoniu S, Banach M (2015) Effect of curcuminoids on oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J Funct Foods 18:898\u2013909","journal-title":"J Funct Foods"},{"issue":"4","key":"2_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.21037\/atm.2019.12.147","volume":"8","author":"W He","year":"2020","unstructured":"He W, Yuan K, Ji B, Han Y, Li J (2020) Protective effects of curcumin against neuroinflammation induced by A\u03b225-35 in primary rat microglia: modulation of high-mobility group box 1, toll-like receptor 4 and receptor for advanced glycation end products expression. Ann Transl Med 8(4):88. https:\/\/doi.org\/10.21037\/atm.2019.12.147","journal-title":"Ann Transl Med"},{"issue":"3","key":"2_CR43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12640-017-9860-4","volume":"33","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Tangwongchai S, Sughondhabhirom A, Suppapitiporn S, Hemrunrojn S, Carvalho AF et al (2018) Add-on treatment with curcumin has antidepressive effects in Thai patients with major depression: results of a randomized double-blind placebo-controlled study. Neurotox Res 33(3):621\u2013633","journal-title":"Neurotox Res"},{"issue":"1","key":"2_CR44","first-page":"1","volume":"29","author":"PP Sordillo","year":"2015","unstructured":"Sordillo PP, Helson L (2015) Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections. In Vivo 29(1):1\u20134","journal-title":"In Vivo"},{"issue":"1","key":"2_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/nu12010118","volume":"12","author":"DJ Den Hartogh","year":"2020","unstructured":"Den Hartogh DJ, Gabriel A, Tsiani E (2020) Antidiabetic properties of curcumin I: evidence from in vitro studies. Nutrients 12(1):118. https:\/\/doi.org\/10.3390\/nu12010118","journal-title":"Nutrients"},{"issue":"3","key":"2_CR46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10565-018-09450-8","volume":"35","author":"E Seyed Hosseini","year":"2019","unstructured":"Seyed Hosseini E, Alizadeh Zarei M, Babashah S, Nakhaei Sistani R, Sadeghizadeh M, Haddad Kashani H et al (2019) Studies on combination of oxaliplatin and dendrosomal nanocurcumin on proliferation, apoptosis induction, and long non-coding RNA expression in ovarian cancer cells. Cell Biol Toxicol 35(3):247\u2013266","journal-title":"Cell Biol Toxicol"},{"issue":"12","key":"2_CR47","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/ijms20122939","volume":"20","author":"T Saghafi","year":"2019","unstructured":"Saghafi T, Taheri RA, Parkkila S, Emameh RZ (2019) Phytochemicals as modulators of long non-coding RNAs and inhibitors of cancer-related carbonic anhydrases. Int J Mol Sci 20(12):2939. https:\/\/doi.org\/10.3390\/ijms20122939","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2_CR48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13402-018-0406-4","volume":"41","author":"R Castro-Oropeza","year":"2018","unstructured":"Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K (2018) The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol 41(6):585\u2013603","journal-title":"Cell Oncol"},{"issue":"3","key":"2_CR49","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/jcp.27069","volume":"234","author":"EB Bian","year":"2019","unstructured":"Bian EB, Xiong ZG, Li J (2019) New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA\u2013miRNA interactions. J Cell Physiol 234(3):2194\u20132203","journal-title":"J Cell Physiol"},{"issue":"41","key":"2_CR50","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng WX, Koirala P, Mo YY (2017) LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36(41):5661\u20135667","journal-title":"Oncogene"},{"issue":"11","key":"2_CR51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","volume":"1839","author":"G Yang","year":"2014","unstructured":"Yang G, Lu X, Yuan L (2014) LncRNA: a link between RNA and cancer. Biochim Biophys Acta 1839(11):1097\u20131109","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2_CR52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","volume":"136","author":"CP Ponting","year":"2009","unstructured":"Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136(4):629\u2013641","journal-title":"Cell"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/ncomms3939","volume":"4","author":"JH Yoon","year":"2013","unstructured":"Yoon JH, Abdelmohsen K, Kim J, Yang X, Martindale JL, Tominaga-Yamanaka K et al (2013) Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun 4:2939. https:\/\/doi.org\/10.1038\/ncomms3939","journal-title":"Nat Commun"},{"issue":"10","key":"2_CR54","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/15476286.2015.1063770","volume":"12","author":"P Han","year":"2015","unstructured":"Han P, Chang CP (2015) Long non-coding RNA and chromatin remodeling. RNA Biol 12(10):1094\u20131098","journal-title":"RNA Biol"},{"issue":"9","key":"2_CR55","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1535-7163.MCT-18-0124","volume":"17","author":"L Zhang","year":"2018","unstructured":"Zhang L, Peng D, Sood AK, Dang CV, Zhong X (2018) Shedding light on the dark cancer genomes: long noncoding RNAs as novel biomarkers and potential therapeutic targets for cancer. Mol Cancer Ther 17(9):1816\u20131823","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"2_CR56","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/ijms19092711","volume":"19","author":"AD Campos-Parra","year":"2018","unstructured":"Campos-Parra AD, L\u00f3pez-Urrutia E, Orozco Moreno LT, L\u00f3pez-Camarillo C, Meza-Menchaca T, Figueroa Gonz\u00e1lez G et al (2018) Long non-coding RNAs as new master regulators of resistance to systemic treatments in breast cancer. Int J Mol Sci 19(9):2711. https:\/\/doi.org\/10.3390\/ijms19092711","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2_CR57","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2017-06-788695","volume":"130","author":"JR Alvarez-Dominguez","year":"2017","unstructured":"Alvarez-Dominguez JR, Lodish HF (2017) Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis. Blood 130(18):1965\u20131975","journal-title":"Blood"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"152983","DOI":"10.1016\/j.prp.2020.152983","volume":"216","author":"XH Du","year":"2020","unstructured":"Du XH, Wei H, Qu GX, Tian ZC, Yao WT, Cai QQ (2020) Gene expression regulations by long noncoding RNAs and their roles in cancer. Pathol Res Pract 216:152983. https:\/\/doi.org\/10.1016\/j.prp.2020.152983. Online ahead of print","journal-title":"Pathol Res Pract"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-981-10-5203-3_7","volume":"1008","author":"A Renganathan","year":"2017","unstructured":"Renganathan A, Felley-Bosco E (2017) Long noncoding RNAs in cancer and therapeutic potential. Adv Exp Med Biol 1008:199\u2013222","journal-title":"Adv Exp Med Biol"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fonc.2018.00327","volume":"8","author":"F Corr\u00e0","year":"2018","unstructured":"Corr\u00e0 F, Agnoletto C, Minotti L, Baldassari F, Volinia S (2018) The network of non-coding RNAs in cancer drug resistance. Front Oncol 8:327. https:\/\/doi.org\/10.3389\/fonc.2018.00327","journal-title":"Front Oncol"},{"issue":"7","key":"2_CR61","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.18632\/oncotarget.13957","volume":"8","author":"MX Cao","year":"2017","unstructured":"Cao MX, Jiang YP, Tang YL, Liang XH (2017) The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity. Oncotarget 8(7):12472\u201312483","journal-title":"Oncotarget"},{"issue":"5","key":"2_CR62","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00280-017-3301-1","volume":"79","author":"H Cao","year":"2017","unstructured":"Cao H, Yu H, Feng Y, Chen L, Liang F (2017) Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3\/miR-143 axis. Cancer Chemother Pharmacol 79(5):985\u2013994","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"2_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198055","volume":"13","author":"Y Ye","year":"2018","unstructured":"Ye Y, Li SL, Wang SY (2018) Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer. PLoS One 13(8):e0198055. https:\/\/doi.org\/10.1371\/journal.pone.0198055","journal-title":"PLoS One"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.2147\/OTT.S121785","volume":"9","author":"Z Peng","year":"2016","unstructured":"Peng Z, Zhang C, Duan C (2016) Functions and mechanisms of long noncoding RNAs in lung cancer. Onco Targets Ther 9:4411\u20134424","journal-title":"Onco Targets Ther"},{"issue":"13","key":"2_CR65","doi-asserted-by":"crossref","first-page":"22187","DOI":"10.18632\/oncotarget.14728","volume":"8","author":"J Luo","year":"2017","unstructured":"Luo J, Qu J, Wu DK, Lu ZL, Sun YS, Qu Q (2017) Long non-coding RNAs: a rising biotarget in colorectal cancer. Oncotarget 8(13):22187\u201322202","journal-title":"Oncotarget"},{"issue":"24","key":"2_CR66","doi-asserted-by":"crossref","first-page":"39859","DOI":"10.18632\/oncotarget.16339","volume":"8","author":"H Li","year":"2017","unstructured":"Li H, Ma SQ, Huang J, Chen XP, Zhou HH (2017) Roles of long noncoding RNAs in colorectal cancer metastasis. Oncotarget 8(24):39859\u201339876","journal-title":"Oncotarget"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/OTT.S127547","volume":"10","author":"T Chen","year":"2017","unstructured":"Chen T, Yang P, Wang H, He ZY (2017) Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells. Onco Targets Ther 10:483\u2013491","journal-title":"Onco Targets Ther"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"153303381987078","DOI":"10.1177\/1533033819870781","volume":"18","author":"H Yu","year":"2019","unstructured":"Yu H, Xie Y, Zhou Z, Wu Z, Dai X, Xu B (2019) Curcumin regulates the progression of colorectal cancer via LncRNA NBR2\/AMPK pathway. Technol Cancer Res Treat 18:1533033819870781. https:\/\/doi.org\/10.1177\/1533033819870781","journal-title":"Technol Cancer Res Treat"},{"issue":"10","key":"2_CR69","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/carcin\/bgx065","volume":"38","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Toden S, Ravindranathan P, Han H, Goel A (2017) Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. Carcinogenesis 38(10):1036\u20131046","journal-title":"Carcinogenesis"},{"issue":"12","key":"2_CR70","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/15384047.2017.1385682","volume":"18","author":"L Duguang","year":"2017","unstructured":"Duguang L, Jin H, Xiaowei Q, Peng X, Xiaodong W, Zhennan L et al (2017) The involvement of lncRNAs in the development and progression of pancreatic cancer. Cancer Biol Ther 18(12):927\u2013936","journal-title":"Cancer Biol Ther"},{"issue":"35","key":"2_CR71","doi-asserted-by":"crossref","first-page":"57379","DOI":"10.18632\/oncotarget.10545","volume":"7","author":"X Huang","year":"2016","unstructured":"Huang X, Zhi X, Gao Y, Ta N, Jiang H, Zheng J (2016) LncRNAs in pancreatic cancer. Oncotarget 7(35):57379\u201357390","journal-title":"Oncotarget"},{"issue":"7","key":"2_CR72","first-page":"402","volume":"73","author":"WH Wang","year":"2018","unstructured":"Wang WH, Chen J, Zhang BR, Lu SJ, Wang F, Peng L et al (2018) Curcumin inhibits proliferation and enhances apoptosis in A549 cells by downregulating lncRNA UCA1. Pharmazie 73(7):402\u2013407","journal-title":"Pharmazie"},{"issue":"5","key":"2_CR73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.gpb.2016.03.007","volume":"14","author":"MM Wei","year":"2016","unstructured":"Wei MM, Zhou GB (2016) Long non-coding RNAs and their roles in non-small-cell lung cancer. Genom Proteom Bioinf 14(5):280\u2013288","journal-title":"Genom Proteom Bioinf"},{"key":"2_CR74","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3389\/fonc.2019.00787","volume":"9","author":"MY Li","year":"2019","unstructured":"Li MY, Tang XH, Fu Y, Wang TJ, Zhu JM (2019) Regulatory mechanisms and clinical applications of the long non-coding RNA PVT1 in cancer treatment. Front Oncol 9:787. https:\/\/doi.org\/10.3389\/fonc.2019.00787","journal-title":"Front Oncol"},{"issue":"2","key":"2_CR75","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7150\/jca.34320","volume":"11","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li H, Li J, Lv X, Yang Z, Gao M et al (2020) Polymorphisms in the PVT1 gene and Susceptibility to the lung cancer in a Chinese northeast population: a case-control study. J Cancer 11(2):468\u2013478","journal-title":"J Cancer"},{"issue":"3","key":"2_CR76","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.18632\/oncotarget.12537","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Ye C, Xiong H, Shen Y, Lu Y, Zhou J et al (2017) Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication. Oncotarget 8(3):5508\u20135522","journal-title":"Oncotarget"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.phymed.2018.03.022","volume":"42","author":"MJD Esmatabadi","year":"2018","unstructured":"Esmatabadi MJD, Motamedrad M, Sadeghizadeh M (2018) Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells. Phytomedicine 42:56\u201365","journal-title":"Phytomedicine"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biopha.2018.03.077","volume":"102","author":"B Rathinasamy","year":"2018","unstructured":"Rathinasamy B, Velmurugan BK (2018) Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals. Biomed Pharmacother 102:242\u2013248","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2_CR79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18869\/acadpub.ibj.21.1.3","volume":"21","author":"E Nikpayam","year":"2017","unstructured":"Nikpayam E, Tasharrofi B, Sarrafzadeh S, Ghafouri-Fard S (2017) The role of long non-coding RNAs in ovarian cancer. Iran Biomed J 21(1):3\u201315","journal-title":"Iran Biomed J"},{"issue":"3","key":"2_CR80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00280-017-3238-4","volume":"79","author":"J Zhang","year":"2017","unstructured":"Zhang J, Liu J, Xu X, Li L (2017) Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer. Cancer Chemother Pharmacol 79(3):479\u2013487","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"2_CR81","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/cas.13352","volume":"108","author":"A Misawa","year":"2017","unstructured":"Misawa A, Ki T, Inoue S (2017) Long non-coding RNAs and prostate cancer. Cancer Sci 108(11):2107\u20132114","journal-title":"Cancer Sci"},{"key":"2_CR82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2018.01.012","volume":"418","author":"Y Mitobe","year":"2018","unstructured":"Mitobe Y, K-i T, Horie-Inoue K, Inoue S (2018) Prostate cancer-associated lncRNAs. Cancer Lett 418:159\u2013166","journal-title":"Cancer Lett"},{"issue":"1","key":"2_CR83","first-page":"20","volume":"42","author":"Y Liu","year":"2019","unstructured":"Liu Y, Sun H, Makabel B, Cui Q, Li J, Su C et al (2019) The targeting of noncoding RNAs by curcumin: facts and hopes for cancer therapy (review). Oncol Rep 42(1):20\u201334","journal-title":"Oncol Rep"},{"issue":"53","key":"2_CR84","doi-asserted-by":"crossref","first-page":"33572","DOI":"10.1039\/C7RA02994B","volume":"7","author":"L Xiao-ai","year":"2017","unstructured":"Xiao-ai L, Bei W, Xiao-hong X, Lei P, Bin W, Xiao-xue D et al (2017) Curcumin re-sensitizes multidrug resistant (MDR) breast cancer to cisplatin through inducing autophagy by decreasing CCAT1 expression. RSC Adv 7(53):33572\u201333579","journal-title":"RSC Adv"},{"issue":"5","key":"2_CR85","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/15384047.2020.1727700","volume":"21","author":"X Li","year":"2020","unstructured":"Li X, Han X, Wei P, Yang J, Sun J (2020) Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Cancer Biol Ther 21(5):452\u2013462","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"2_CR86","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.7314\/APJCP.2014.15.10.4239","volume":"15","author":"CS Pei","year":"2014","unstructured":"Pei CS, Wu HY, Fan FT, Wu Y, Shen CS, Pan LQ (2014) Influence of curcumin on HOTAIR-mediated migration of human renal cell carcinoma cells. Asian Pac J Cancer Prev 15(10):4239\u20134243","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"2_CR87","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbrc.2019.01.116","volume":"510","author":"K Sun","year":"2019","unstructured":"Sun K, Jia Z, Duan R, Yan Z, Jin Z, Yan L et al (2019) Long non-coding RNA XIST regulates miR-106b-5p\/P21 axis to suppress tumor progression in renal cell carcinoma. Biochem Biophys Res Commun 510(3):416\u2013420","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2_CR88","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.phymed.2015.05.071","volume":"22","author":"M Zamani","year":"2015","unstructured":"Zamani M, Sadeghizadeh M, Behmanesh M, Najafi F (2015) Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer. Phytomedicine 22(10):961\u2013967","journal-title":"Phytomedicine"},{"issue":"6","key":"2_CR89","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.3892\/ol.2016.5354","volume":"12","author":"G Liu","year":"2016","unstructured":"Liu G, Xiang T, Wu QF, Wang WX (2016) Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19. Oncol Lett 12(6):5156\u20135162","journal-title":"Oncol Lett"},{"issue":"3","key":"2_CR90","first-page":"507","volume":"39","author":"QR Wang","year":"2014","unstructured":"Wang QR, Fan HN, Yin ZX, Cai HB, Shao M, Diao JX, Liu YL, Sun XG, Tong L, Fan Q (2014) Effect of curcumin on radiosensitization of CNE-2 cells and its mechanism. Zhongguo Zhongyao Zazhi 39(3):507\u2013510","journal-title":"Zhongguo Zhongyao Zazhi"},{"issue":"3","key":"2_CR91","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3892\/ijo.2013.2237","volume":"44","author":"Q Wang","year":"2014","unstructured":"Wang Q, Fan H, Liu Y, Yin Z, Cai H, Liu J, Wang Z, Shao M, Sun X, Diao J (2014) Curcumin enhances the radiosensitivity in nasopharyngeal carcinoma cells involving the reversal of diferentially expressed long non-coding RNAs. Int J Oncol 44(3):858\u2013864","journal-title":"Int J Oncol"}],"container-title":["Advances in Experimental Medicine and Biology","Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-64872-5_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T14:10:39Z","timestamp":1620655839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-64872-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030648718","9783030648725"],"references-count":91,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-64872-5_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"17 April 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}